Literature DB >> 8832711

A radioimmunoimaging and MIRD dosimetry treatment planning program for radioimmunotherapy.

W D Erwin1, M W Groch, D J Macey, G L DeNardo, S J DeNardo, S Shen.   

Abstract

A treatment planning program for radioimmunotherapy employing quantitative Anger camera imaging and the MIRD formalism has been designed and implemented on a clinical nuclear medicine computer. Radionuclide residence times are calculated from linear, mono- and bi-exponential, and cubic spline fits to regional activity versus time curves, and radiation-absorbed dose estimates for all target organs for 131I, 67Cu, and 58 other radionuclides can be calculated. This software has been successfully applied to radioimmunotherapy of B-cell malignancies and breast adenocarcinomas.

Entities:  

Mesh：

Year:  1996        PMID： 8832711     DOI： 10.1016/0969-8051(96)00036-4

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN： 0969-8051            Impact factor:   2.408


  6 in total

1.  Software package for integrated data processing for internal dose assessment in nuclear medicine (SPRIND).

Authors:  Eric Visser; Ernst Postema; Otto Boerman; Jeroen Visschers; Wim Oyen; Frans Corstens
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-11-15       Impact factor: 9.236

2.  In-vivo biodistribution and safety of 99mTc-LLP2A-HYNIC in canine non-Hodgkin lymphoma.

Authors:  Allison L Zwingenberger; Michael S Kent; Ruiwu Liu; David L Kukis; Erik R Wisner; Sally J DeNardo; Sandra L Taylor; Xiucui Chen; Kit S Lam
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

3.  Radiation dosimetry and biodistribution of (99m)Tc-ethylene dicysteine-deoxyglucose in patients with non-small-cell lung cancer.

Authors:  Naomi R Schechter; William D Erwin; David J Yang; E Edmund Kim; Reginald F Munden; Kenneth Forster; Lina C Taing; James D Cox; Homer A Macapinlac; Donald A Podoloff
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04-25       Impact factor: 9.236

4.  Evaluation of effective dose for a patient under Ga-67 nuclear examination using TLD, water phantom and a simplified model.

Authors:  Kuang Hua Chu; Yu Ting Lin; Chia Chun Hsu; Chien Yi Chen; Lung Kwang Pan
Journal:  J Radiat Res       Date:  2012-08-21       Impact factor: 2.724

5.  Production, biodistribution, and dosimetry of (47)Sc-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylene phosphonic acid as a bone-seeking radiopharmaceutical.

Authors:  Fatemeh Fathi; Leila Moghaddam-Banaem; Mojtaba Shamsaei; Ali Samani; Mohammad G Maragheh
Journal:  J Med Phys       Date:  2015 Jul-Sep

6.  Dosimetry of 175Ytterbium-poly (amidoamine) Therapy for Humans' Organs.

Authors:  Navideh Aghaei-Amirkhizi; Sodeh Sadjadi; Leila Moghaddam-Banaem; Mitra Athari-Allaf; Fariba Johari-Deha
Journal:  J Med Phys       Date:  2018 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.